Improvement of aptamer affinity by dimerization

被引:128
作者
Hasegawa, Hijiri [1 ]
Taira, Ken-ichi [1 ]
Sode, Koji [1 ]
Ikebukuro, Kazunori [1 ]
机构
[1] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan
关键词
aptamer; dimerization; avidity;
D O I
10.3390/s8021090
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
To increase the affinities of aptamers for their targets, we designed an aptamer dimer for thrombin and VEGF. This design is based on the avidity of the antibody, which enables the aptamer to connect easily since it is a single-strand nucleic acid. In this study, we connected a 15-mer thrombin-binding aptamer with a 29-mer thrombin-binding aptamer. Each aptamer recognizes a different part of the thrombin molecule, and the aptamer dimer has a K-d value which is 1/10 of that of the monomers from which it is composed. Also, the designed aptamer dimer has higher inhibitory activity than the reported (15-mer) thrombin-inhibiting aptamer. Additionally, we connected together two identical aptamers against vascular endothelial growth factor (VEGF(165)), which is a homodimeric protein. As in the case of the anti-thrombin aptamer, the dimeric anti-VEGF aptamer had a much lower Kd value than that of the monomer. This study demonstrated that the dimerization of aptamers effectively improves the affinities of those aptamers for their targets.
引用
收藏
页码:1090 / 1098
页数:9
相关论文
共 18 条
[1]   Generating improved single-chain Fv molecules for tumor targeting [J].
Adams, GP ;
Schier, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) :249-260
[2]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[3]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[4]   Protein detection using proximity-dependent DNA ligation assays [J].
Fredriksson, S ;
Gullberg, M ;
Jarvius, J ;
Olsson, C ;
Pietras, K ;
Gústafsdóttir, SM ;
Östman, A ;
Landegren, U .
NATURE BIOTECHNOLOGY, 2002, 20 (05) :473-477
[5]  
HASEGAWA H, 2008, BIOTECHNOL LETT
[6]  
Jayasena SD, 1999, CLIN CHEM, V45, P1628
[7]   Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer [J].
Mueller, Jens ;
Wulffen, Bernhard ;
Poetzsch, Bernd ;
Mayer, Gunter .
CHEMBIOCHEM, 2007, 8 (18) :2223-2226
[8]   Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site [J].
Muller, YA ;
Li, B ;
Christinger, HW ;
Wells, JA ;
Cunningham, BC ;
DeVos, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7192-7197
[9]   Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis [J].
Nakahara, H ;
Song, H ;
Sugimoto, M ;
Hagihara, K ;
Kishimoto, T ;
Yoshizaki, K ;
Nishimoto, N .
ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1521-1529
[10]   HIGH-AFFINITY ANTIGEN-BINDING BY CHELATING-RECOMBINANT-ANTIBODIES (CRABS) [J].
NERI, D ;
MOMO, M ;
PROSPERO, T ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 246 (03) :367-373